TriPath Expanded Pap Labeling Data Claim Closes Gap With Cytyc

TriPath expects narrower price differences between its SurePath and Cytyc's ThinPrep Pap test alternative over the long-term after receiving FDA sign-off on labeling that puts the tests on par for efficacy